Edwards Lifesciences Corp (EW)
71.90 x 1 77.60 x 1
Post-market by (Cboe BZX)
76.04 +0.91 (+1.21%) 04/25/25 [NYSE]
71.90 x 1 77.60 x 1
Post-market 76.04 unch (unch) 17:42 ET
for Fri, Apr 25th, 2025
Results
download Want to compare other data? Select Fields| Symbol | EW | ALC | IDXX | ||
| Company | Edwards Lifesciences Corp | Alcon Inc | Idexx Laboratories | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 74.82 | 95.00 | 438.63 | ||
| High | 76.10 | 95.15 | 440.50 | ||
| Low | 74.10 | 94.49 | 432.08 | ||
| Last | 76.04 | 94.94 | 437.44 | ||
| Change | +0.91 | +0.26 | -3.54 | ||
| % Change | +1.21% | +0.27% | -0.80% | ||
| Volume | 6,330,100 | 665,100 | 939,200 | ||
| 20-Day Average Volume | 5,379,510 | 1,930,520 | 1,073,880 | ||
| Previous Close | 75.13 | 94.68 | 440.98 | ||
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 70.90 | 90.82 | 407.54 | ||
| 20-Day Raw Stochastic | 97.58% | 90.96% | 94.83% | ||
| 20-Day Relative Strength | 61.34% | 56.90% | 56.25% | ||
| Weighted Alpha | +2.72 | +17.11 | -10.60 | ||
| Today's Opinion | 56% Buy | 32% Buy | 24% Sell | ||
| Previous Opinion | 32% Buy | 48% Buy | 24% Sell | ||
| Last Month's Opinion | 40% Sell | 40% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.31% since 04/17/25 | +2.59% since 04/17/25 | +6.31% since 04/17/25 | ||
| Low | 68.63 on 04/21/25 | 90.69 on 04/21/25 | 402.85 on 04/21/25 | ||
| High | 76.29 on 04/24/25 | 95.33 on 04/23/25 | 441.87 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | +6.74% since 03/25/25 | +2.31% since 03/25/25 | +4.74% since 03/25/25 | ||
| Low | 65.94 on 04/09/25 | 80.48 on 04/07/25 | 356.14 on 04/09/25 | ||
| High | 76.29 on 04/24/25 | 97.40 on 03/27/25 | 441.87 on 04/24/25 | ||
| 3-Month | |||||
| %Chg | +10.22% since 01/24/25 | +6.72% since 01/24/25 | +0.48% since 01/24/25 | ||
| Low | 65.94 on 04/09/25 | 80.48 on 04/07/25 | 356.14 on 04/09/25 | ||
| High | 76.73 on 02/14/25 | 97.40 on 03/27/25 | 474.67 on 02/03/25 | ||
| 6-Month | |||||
| %Chg | +9.60% since 10/25/24 | +0.73% since 10/25/24 | -3.09% since 10/25/24 | ||
| Low | 64.89 on 11/12/24 | 80.48 on 04/07/25 | 356.14 on 04/09/25 | ||
| High | 76.73 on 02/14/25 | 97.40 on 03/27/25 | 474.67 on 02/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 44,701,256 | 46,828,584 | 35,449,700 | ||
| Shares Outstanding, K | 587,865 | 493,244 | 81,039 | ||
| Annual Sales | 5,439,500,000 | 9,911,000,000 | 3,897,500,000 | ||
| Annual Net Income | 4,174,600,000 | 1,018,000,000 | 887,870,000 | ||
| Last Quarter Sales | 1,101,000,000 | 2,502,000,000 | 954,290,000 | ||
| Last Quarter Net Income | 385,600,000 | 284,000,000 | 216,150,000 | ||
| 60-Month Beta | 1.15 | 0.99 | 1.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.64 on 04/23/25 | 0.72 on 02/25/25 | 2.62 on 02/03/25 | ||
| Latest Earnings Date | 04/23/25 | 05/13/25 | 05/01/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 28.90 | 31.04 | 41.33 | ||